Article
KANSL1 gene disruption associated with the full clinical spectrum of 17q21.31 microdeletion syndrome.
BMC medical genetics - 22 Aug 2015
Moreno-Igoa María, Hernández-Charro Blanca, Bengoa-Alonso Amaya, Pérez-Juana-del-Casal Aranzazu, Romero-Ibarra Carlos, Nieva-Echebarria Beatriz, Ramos-Arroyo María Antonia
Abstract excerpt
BACKGROUND: Chromosome 17q21.31 microdeletion syndrome is a multisystem genomic disorder caused by a recurrent 600-kb-long deletion, or haploinsufficiency of the chromatin modifier gene KANSL1, which maps to that region. Patients with KANSL1 intragenic mutations have been reported to display the major clinical features of 17q21.31 microdeletion syndrome. However, they did not exhibit the full clinical spectrum of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
